FDA Investigator Carol A Gripp
Carol A Gripp has inspections in 3 countries as of 07 Sep 2023. Carol A Gripp has collaborated with a combined 458 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
07 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
India,
United States of America,
France
Co-Investigator(s):
Anita Narula, PhD,
Carl A Anderson,
Dennis Cantellops Paite,
Janice K Pohlman, MD, MPH,
Jose Alopez Rubet,
Jose M Cayuela,
Justin A Boyd,
Katherine Szestypalow,
Kenneth O Gee, PhD,
Libia M Lugo,
Maria Pkelly Doggett, MBA,
Matthew B Casale,
Michael A Taylor,
Michael L Chasey,
Michele L Glendenning,
Ramon A Hernandez,
Randy L Self,
Sandra A Boyd,
Sandra A Hughes,
Savini,
Scott B Laufenberg,
Scott W Fox,
State Agency,
Sunitha K Rajaram, PhD,
Yumi J Hiramine
Carol A Gripp's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2013 | FDA 483 | Glenmark Pharmaceuticals Limited - Form 483, 2013-07-19 |
February, 2002 | EIR | Sanofi-Synthelabo - EIR, 2002-02-21 |
July, 2014 | FDA 483 | Hawkins, Douglas, MD - Form 483, 2014-07-02 |
February, 2002 | FDA 483 Response | Sanofi-Synthelabo - Form 483R, 2002-03-25 |
July, 2014 | EIR | Hawkins, Douglas, MD - EIR, 2014-07-02 |
July, 2013 | EIR | Glenmark Pharmaceuticals Limited - EIR, 2013-07-19 |
February, 2002 | FDA 483 | Sanofi-Synthelabo - Form 483, 2002-02-21 |
August, 2013 | EIR | Emerald Kalama Chemical, LLC - EIR, 2013-10-18 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more